Document Detail


Acute cardiovascular effects of the calcimimetic R-568 and its enantiomer S-568 in rats.
MedLine Citation:
PMID:  19280225     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Calcimimetics increase the sensitivity of the calcium sensing receptor (CaSR) to calcium ions (Ca(2+)) and allow for efficient control of uraemic hyperparathyroidism. Recent studies suggested an additional blood pressure-lowering action, the underlying mechanisms are as yet unknown. We infused R-568 and its enantiomer S-568, which has little activity at the CaSR, in anaesthetized rats. Mean arterial blood pressure (MAP) and heart rate (HR) were measured in the femoral artery; renal blood flow (RBF) and mesenteric blood flow (MBF) were measured locally. Infusion of R-568 at 0.7 mg/kg per 10 min into the femoral vein, a dose known to reduce levels of parathyroid hormone (PTH) and Ca(2+) in plasma, did not affect blood pressure or heart rate. Infusion of 2.1 mg/kg per 3 min of R-568 and S-568 into the femoral vein significantly reduced MAP by 26 +/- 4.5 and 23.7 +/- 3.1% and HR by 7.8 +/- 2.9 and 5.8 +/- 2.0%, respectively. Intra-arterial infusions of R-568 increased blood flow in a dose-dependent fashion. At plasma concentrations of 70 micromol/l R-568 and S-568 increased RBF by 17 +/- 3 and 15 +/- 3% and MBF by 28 +/- 5 and 29 +/- 5%. The effects on blood flow were greater in the mesenteric artery than in the renal artery, but not different between both compounds.The calcimimetic R-568 exerts acute, CaSR-independent, hypotensive effects via vasodilation and negative chronotropy at concentrations exceeding those required for modulation of PTH secretion.
Authors:
Kumiko Nakagawa; Niru Parekh; Nadezda Koleganova; Eberhard Ritz; Franz Schaefer; Claus Peter Schmitt
Related Documents :
8928845 - Medullary blood flow responses to changes in arterial pressure in canine kidney.
20056745 - Angiotensin ii promotes development of the renal microcirculation through at1 receptors.
6166805 - Hemodynamic profile of a new antihypertensive agent d,l-3-[2-(3-t-butylamino-2-hydroxyp...
21914035 - A micro-delivery approach for studying microvascular responses to localized oxygen deli...
11924805 - Optimization of intraperitoneal injection anesthesia in mice: drugs, dosages, adverse e...
7535035 - Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and men...
Publication Detail:
Type:  Journal Article     Date:  2009-03-12
Journal Detail:
Title:  Pediatric nephrology (Berlin, Germany)     Volume:  24     ISSN:  1432-198X     ISO Abbreviation:  Pediatr. Nephrol.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-01     Completed Date:  2009-08-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8708728     Medline TA:  Pediatr Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1385-9     Citation Subset:  IM    
Affiliation:
Division of Paediatric Nephrology, Centre for Paediatric and Adolescent Medicine, University of Heidelberg, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aniline Compounds / administration & dosage*,  chemistry
Animals
Blood Pressure / drug effects
Cardiovascular System / drug effects
Dose-Response Relationship, Drug
Heart Rate / drug effects
Male
Rats
Rats, Sprague-Dawley
Receptors, Calcium-Sensing / drug effects
Renal Circulation / drug effects
Splanchnic Circulation / drug effects*
Stereoisomerism
Chemical
Reg. No./Substance:
0/Aniline Compounds; 0/N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine; 0/Receptors, Calcium-Sensing

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enhanced docosahexaenoic acid production by reinforcing acetyl-CoA and NADPH supply in Schizochytriu...
Next Document:  Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide.